Compounds > celecoxib

celecoxib and sulindac sulfide

celecoxib has been researched along with sulindac sulfide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blobaum, AL; Crews, BC; Daniel, CM; Ghebreselasie, K; Kingsley, PJ; Liedtke, AJ; Marnett, LJ1
Bedford, NS; Bock, JM; Domann, FE; Goswami, PC; Menon, SG; Sinclair, LL; Trask, DK1
Grimaldi, M; Hobrath, JV; Johnson, GG; Piazza, GA; White, MC; Zhang, W1
Acuna, UM; Einbond, LS; Figueroa, M; Foster, DA; Jalees, F; Kashiwazaki, R; Kennelly, EJ; Le Gendre, O; Mighty, J1
Chen, CH; Cheng, TS; Hsiao, PW; Hsu, TW; Huang, HP; Ko, CJ; Lai, PF; Lan, SW; Lee, MS; Lin, HH; Lin, HY; Lu, YC; Shyu, HY; Tsai, CH; Wu, SR1

Other Studies

5 other study(ies) available for celecoxib and sulindac sulfide

ArticleYear
Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.
    Journal of medicinal chemistry, 2012, Mar-08, Volume: 55, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Screening Assays, Antitumor; Female; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Sheep; Stereoisomerism; Structure-Activity Relationship; Sulindac

2012
Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibition.
    Molecular carcinogenesis, 2007, Volume: 46, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Celecoxib; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; E2F Transcription Factors; G1 Phase; Humans; Pyrazoles; Sulfonamides; Sulindac; Tumor Cells, Cultured

2007
Sulindac sulfide inhibits sarcoendoplasmic reticulum Ca2+ ATPase, induces endoplasmic reticulum stress response, and exerts toxicity in glioma cells: relevant similarities to and important differences from celecoxib.
    Journal of neuroscience research, 2013, Volume: 91, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Glioma; Humans; Pyrazoles; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sulfonamides; Sulindac

2013
Garcinia benzophenones inhibit the growth of human colon cancer cells and synergize with sulindac sulfide and turmeric.
    Anti-cancer agents in medicinal chemistry, 2013, Volume: 13, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Benzophenones; Butadienes; Celecoxib; Cell Cycle Proteins; Cell Line, Tumor; Curcuma; Dose-Response Relationship, Drug; Drug Synergism; Endoplasmic Reticulum; Enzyme Inhibitors; Epithelial Cells; Garcinia; Gene Expression Regulation, Neoplastic; Heparin; Humans; Inositol 1,4,5-Trisphosphate Receptors; Mechanistic Target of Rapamycin Complex 1; Mitogen-Activated Protein Kinases; Multiprotein Complexes; Nitriles; Phosphoproteins; Plant Extracts; Pyrazoles; Signal Transduction; Structure-Activity Relationship; Sulfonamides; Sulindac; TOR Serine-Threonine Kinases

2013
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.
    Oncogene, 2017, 08-10, Volume: 36, Issue:32

    Topics: Animals; Celecoxib; Cell Movement; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; HEK293 Cells; Humans; Inflammation; Interleukin-2; Male; Membrane Proteins; Mice; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Prostatic Neoplasms; Serine Endopeptidases; Sulindac; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2017